CRESTWOOD, KY, Liberate Medical, an emerging leader in the development of novel non-invasive neurostimulation devices, announced a $6.2M Series B funding round.
Liberate Medical, an emerging leader in the development of novel non-invasive neurostimulation devices focused on transforming respiratory care, announced a $6.2 million Series B funding round led by Scientific Health Development.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
